311 related articles for article (PubMed ID: 19371267)
1. Effect of atorvastatin on microRNA 221 / 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease.
Minami Y; Satoh M; Maesawa C; Takahashi Y; Tabuchi T; Itoh T; Nakamura M
Eur J Clin Invest; 2009 May; 39(5):359-67. PubMed ID: 19371267
[TBL] [Abstract][Full Text] [Related]
2. Effect of intensive lipid-lowering therapy on telomere erosion in endothelial progenitor cells obtained from patients with coronary artery disease.
Satoh M; Minami Y; Takahashi Y; Tabuchi T; Itoh T; Nakamura M
Clin Sci (Lond); 2009 May; 116(11):827-35. PubMed ID: 19090788
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.
Tabuchi T; Satoh M; Itoh T; Nakamura M
Clin Sci (Lond); 2012 Aug; 123(3):161-71. PubMed ID: 22364258
[TBL] [Abstract][Full Text] [Related]
4. Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells.
Rupp S; Badorff C; Koyanagi M; Urbich C; Fichtlscherer S; Aicher A; Zeiher AM; Dimmeler S
Basic Res Cardiol; 2004 Jan; 99(1):61-8. PubMed ID: 14685707
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease.
Zhang Q; Kandic I; Kutryk MJ
Biochem Biophys Res Commun; 2011 Feb; 405(1):42-6. PubMed ID: 21195052
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study.
Spadaccio C; Pollari F; Casacalenda A; Alfano G; Genovese J; Covino E; Chello M
J Cardiovasc Pharmacol; 2010 Jan; 55(1):30-8. PubMed ID: 19834333
[TBL] [Abstract][Full Text] [Related]
7. Prospective, randomized, single-blind comparison of effects of 6 months' treatment with atorvastatin versus pravastatin on leptin and angiogenic factors in patients with coronary artery disease.
Takahashi Y; Satoh M; Tabuchi T; Nakamura M
Heart Vessels; 2012 Jul; 27(4):337-43. PubMed ID: 21643812
[TBL] [Abstract][Full Text] [Related]
8. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.
Giraldez RR; Giugliano RP; Mohanavelu S; Murphy SA; McCabe CH; Cannon CP; Braunwald E
J Am Coll Cardiol; 2008 Sep; 52(11):914-20. PubMed ID: 18772061
[TBL] [Abstract][Full Text] [Related]
9. Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels.
Takahashi Y; Satoh M; Minami Y; Tabuchi T; Itoh T; Nakamura M
Clin Sci (Lond); 2010 Jul; 119(9):395-405. PubMed ID: 20524934
[TBL] [Abstract][Full Text] [Related]
10. Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: effect of statins on let-7i and Toll-like receptor 4 signal.
Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
Immunobiology; 2012 May; 217(5):533-9. PubMed ID: 21899916
[TBL] [Abstract][Full Text] [Related]
11. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease--a randomized, placebo-controlled study.
Alber HF; Frick M; Suessenbacher A; Doerler J; Schirmer M; Stocker EM; Dichtl W; Pachinger O; Weidinger F
Am Heart J; 2006 Jan; 151(1):139. PubMed ID: 16368305
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of the immune system in primary hypercholesterolaemia: effect of atorvastatin therapy.
Sampietro T; Bigazzi F; Rossi G; Dal Pino B; Puntoni MR; Sbrana F; Chella E; Bionda A
J Intern Med; 2005 Jun; 257(6):523-30. PubMed ID: 15910556
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy.
Fichtlscherer S; Schmidt-Lucke C; Bojunga S; Rössig L; Heeschen C; Dimmeler S; Zeiher AM
Eur Heart J; 2006 May; 27(10):1182-90. PubMed ID: 16621868
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin and rosuvastatin mobilize Endothelial Progenitor Cells but do not prevent their acute decrease during systemic inflammation.
Spiel AO; Mayr FB; Leitner JM; Firbas C; Sieghart W; Jilma B
Thromb Res; 2008; 123(1):108-13. PubMed ID: 18433844
[TBL] [Abstract][Full Text] [Related]
15. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes.
Assmus B; Urbich C; Aicher A; Hofmann WK; Haendeler J; Rössig L; Spyridopoulos I; Zeiher AM; Dimmeler S
Circ Res; 2003 May; 92(9):1049-55. PubMed ID: 12676819
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of the microRNA-31-microRNA-720 pathway in the plasma and endothelial progenitor cells from patients with coronary artery disease.
Wang HW; Huang TS; Lo HH; Huang PH; Lin CC; Chang SJ; Liao KH; Tsai CH; Chan CH; Tsai CF; Cheng YC; Chiu YL; Tsai TN; Cheng CC; Cheng SM
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):857-69. PubMed ID: 24558106
[TBL] [Abstract][Full Text] [Related]
17. Combined use of extended-release niacin and atorvastatin: safety and effects on lipid modification.
Sang ZC; Wang F; Zhou Q; Li YH; Li YG; Wang HP; Chen SY
Chin Med J (Engl); 2009 Jul; 122(14):1615-20. PubMed ID: 19719960
[TBL] [Abstract][Full Text] [Related]
18. Effects of atorvastatin and pravastatin on glucose tolerance, adipokine levels and inflammatory markers in hypercholesterolaemic patients.
Ando H; Sugimoto K; Yanagihara H; Tsuruoka S; Saito T; Takamura T; Kaneko S; Fujimura A
Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1012-7. PubMed ID: 18430053
[TBL] [Abstract][Full Text] [Related]
19. Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy.
Schmidt-Lucke C; Fichtlscherer S; Rössig L; Kämper U; Dimmeler S
Atherosclerosis; 2010 Jul; 211(1):249-54. PubMed ID: 20211468
[TBL] [Abstract][Full Text] [Related]
20. Habitual physical activity is associated with endothelial function and endothelial progenitor cells in patients with stable coronary artery disease.
Luk TH; Dai YL; Siu CW; Yiu KH; Chan HT; Fong DY; Lee SW; Li SW; Tam S; Lau CP; Tse HF
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):464-71. PubMed ID: 19587603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
